Advanced search
Publication Cover
Current Medical Research and Opinion Volume 31, 2015 - Issue 2
Submit an article Journal homepage
778
Views
5
CrossRef citations to date
0
Altmetric
Original article

Treatment patterns and survival in metastatic breast cancer patients by tumor characteristics

Yanni HaoNovartis Pharmaceuticals, East Hanover, NJ, USACorrespondence[email protected]
,
Nicole MeyerTruven Health Analytics, Cambridge, MA, USA
,
Xue SongTruven Health Analytics, Cambridge, MA, USA
,
Nianwen ShiTruven Health Analytics, Cambridge, MA, USA
,
William JohnsonTruven Health Analytics, Cambridge, MA, USA
,
Paul JuneauTruven Health Analytics, Cambridge, MA, USA
,
Denise A. YardleySarah Cannon Research Institute, Nashville, TN, USA;Tennessee Oncology PLLC, Nashville, TN, USA
&
Jaqueline Willemann RogerioNovartis Pharmaceuticals, East Hanover, NJ, USA
 show all
Pages 275-288 | Accepted 23 Oct 2014, Published online: 27 Jan 2015

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Ravi K. Goyal, Gebra Cuyun Carter, Saurabh P. Nagar, Emily Nash Smyth, Gregory L. Price, Rohan C. Parikh, Yu-Jing Huang, Li Li, Keith L. Davis & James A. Kaye. (2021) Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2– metastatic breast cancer in the United States. Expert Review of Pharmacoeconomics & Outcomes Research 21:4, pages 699-710.
Read now
Ravi K. Goyal, Gebra Cuyun Carter, Saurabh P. Nagar, Emily N. Smyth, Gregory L. Price, Yu-Jing Huang, Li Li, Keith L. Davis & James A. Kaye. (2019) Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2− metastatic breast cancer. Current Medical Research and Opinion 35:10, pages 1699-1710.
Read now
Debra E. Irwin, Anthony Masaquel, Stephen Johnston & Brian Barnett. (2016) Adverse event-related costs for systemic metastatic breast cancer treatment among female Medicaid beneficiaries. Journal of Medical Economics 19:11, pages 1027-1033.
Read now

Articles from other publishers (2)

Luis Manso, Alfonso Sanchez-Muñoz, Isabel Calvo, Yann Izarzugaza, Jessica Plata & Cesar Rodriguez. (2018) Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast Cancer. Breast Care 13:4, pages 277-283.
Crossref
Nicole M Engel-Nitz, Yanni Hao, Laura K Becker & Randall Gerdes. (2015) Costs and mortality of recurrent versus de novo hormone receptor-positive/HER2 - metastatic breast cancer . Journal of Comparative Effectiveness Research 4:4, pages 303-314.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.